PuSH - Publication Server of Helmholtz Zentrum München: Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Stacey, D.* ; Chen, L.* ; Stanczyk, P.J.* ; Howson, J.M.M.* ; Mason, A.M.* ; Burgess, S.* ; MacDonald, S.* ; Langdown, J.* ; McKinney, H.* ; Downes, K.* ; Farahi, N.* ; Peters, J.E.* ; Basu, S.* ; Pankow, J.S.* ; Tang, W.* ; Pankratz, N.* ; Sabater-Lleal, M.* ; de Vries, P.S.* ; Smith, N.L.* ; CHARGE Hemostasis Working Group (Peters, A.) ; Gelinas, A.D.* ; Schneider, D.J.* ; Janjic, N.* ; Samani, N.J.* ; Ye, S.* ; Summers, C.* ; Chilvers, E.R.* ; Paul, D.S.*

Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus.

Nat. Commun. 13:1222 (2022)

Publ. Version/Full Text

Research data

DOI

PMC

	Open Access Gold

Abstract
Metrics
Extra information

Many individual genetic risk loci have been associated with multiple common human diseases. However, the molecular basis of this pleiotropy often remains unclear. We present an integrative approach to reveal the molecular mechanism underlying the PROCR locus, associated with lower coronary artery disease (CAD) risk but higher venous thromboembolism (VTE) risk. We identify PROCR-p.Ser219Gly as the likely causal variant at the locus and protein C as a causal factor. Using genetic analyses, human recall-by-genotype and in vitro experimentation, we demonstrate that PROCR-219Gly increases plasma levels of (activated) protein C through endothelial protein C receptor (EPCR) ectodomain shedding in endothelial cells, attenuating leukocyte-endothelial cell adhesion and vascular inflammation. We also associate PROCR-219Gly with an increased pro-thrombotic state via coagulation factor VII, a ligand of EPCR. Our study, which links PROCR-219Gly to CAD through anti-inflammatory mechanisms and to VTE through pro-thrombotic mechanisms, provides a framework to reveal the mechanisms underlying similar cross-phenotype associations.

Impact Factor

Scopus SNIP

Altmetric

17.694

3.341